Latest Breaking News On - Maury raycroft - Page 9 : comparemela.com

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2023 Earnings Call Transcript

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2023 Earnings Call Transcript August 3, 2023 BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.24 EPS, expectations were $0.25. Operator: Good morning and welcome to the BioCryst Second Quarter 2023 Earnings Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn […]

BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript

BCRX earnings call for the period ending June 30, 2023.

Karyopharm Therapeutics (KPTI) Q2 2023 Earnings Call Transcript

KPTI earnings call for the period ending June 30, 2023.

StockWatch: Investors Shrug as FDA Weighs First Gene-Edited Therapy

IDEAYA Biosciences to Participate in Upcoming June 2023 Investor Relations Events

/PRNewswire/ IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted.